A CRISPR activation screen identified a risk variant in an enhancer region of the IL2RA gene (47) and more recently MPRA was used to prioritize approximately 18,000 autoimmune disease associated-variants based on how they perturb regulatory elements in T cells (66). The gene discussed is IL2RA; the disease is autoimmune disease.